Treatment of plasmodium vivax malaria - Time for a change?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 1, 1997, Pages 76-

  Doherty, J F ^a   Day, J H ^a   Warhurst, D C ^a   Chiodini, P L ^a  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

Chemotherapy; Malaria; Plasmodium vivax; Primaquine

Indexed keywords

ANTIMALARIAL AGENT; PRIMAQUINE;

HUMAN; MALARIA; PLASMODIUM VIVAX; SHORT SURVEY;

EID: 0031058089     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90403-X     Document Type: Article

References (4)

1. Anonymous (1991). Primaquine (phosphate). In: Therapeutic Drugs, Dollery, C. (editor). London: Churchill Livingstone, pp. 209-213.
2. Bunnag, D., Karbwang, J., Thanavibul, A., Chittamas, S., Ratanapongse, Y., Chalermrut, K., Na Bangchang, K. & Harinasuta, T. (1994). High dose of primaquine in primaquine resistant vivax malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 218-219.
3. Luzzi, G. A., Warrell, D. A., Barnes, A. J. & Dunbar, E. M. (1992).Treatment of primaquine-resistant Plasmodium vivax malaria. Lancet, 340, 310.
4. Warrell, D. A. (1993). Treatment and prevention of malaria. In: Bruce-Chwatt's Essential Malariology, Gillies, H. M. & Warrell, D. A. (editors). London: Edward Arnold, pp. 164-192.